UBS Group’s HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HPX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,430
Closed -$3.12K 11347
2022
Q4
$3.12K Sell
7,430
-9,550
-56% -$3.55K ﹤0.01% 9562
2022
Q3
$4K Buy
+16,980
New +$5.05K ﹤0.01% 9473
2022
Q2
Sell
-22,220
Closed -$4K 11445
2022
Q1
$4K Buy
22,220
+18,100
+439% +$6.19K ﹤0.01% 9382
2021
Q4
$2K Buy
+4,120
New +$2.76K ﹤0.01% 9899
2021
Q2
Sell
-2,879
Closed -$2K 10075
2021
Q1
$2K Buy
+2,879
New +$3.94K ﹤0.01% 8685

UBS Group's HPX.WS Position: Q1 2023 in Review

UBS Group sold out of HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HPX.WS) in Q1 2023, closing a stake of 7,430 shares — an estimated $3.12K sold.

UBS Group first reported a position in HPX.WS in Q1 2021 and held it in 5 quarters. The position peaked at $4K in Q3 2022. 0 funds tracked by Wall St. Rank hold HPX.WS as of Q1 2023.

  • UBS Group reported no remaining HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 7,430 HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2023, an estimated $3.12K.
  • UBS Group first reported a position in HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 5 quarters.
  • UBS Group's HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $4K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.